Start for free
Start for free
Lifeforce Capital logo

Lifeforce Capital

North America, California, United States, San Francisco

Description

Lifeforce Capital invests in digital health companies enabling new care delivery models or more efficient therapeutic development.

Investor Profile

Lifeforce Capital has made 51 investments, with 1 in the past 12 months and 12% as lead.

Stage Focus

  • Series A (41%)
  • Series B (20%)
  • Seed (18%)
  • Series C (10%)
  • Series Unknown (6%)
  • Series D (2%)
  • Post Ipo Equity (2%)
  • Private Equity (2%)

Country Focus

  • United States (94%)
  • United Kingdom (6%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Software
  • Hospital
  • Health Diagnostics
  • Life Science
  • Clinical Trials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Lifeforce Capital frequently co-invest with?

First Round Capital
First Round Capital
North America, California, United States, San Francisco
Co-Investments: 5
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 5
Google Ventures
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 5
IV
Industry Ventures
North America, California, United States, San Francisco
Co-Investments: 6
Refactor
Refactor
North America, California, United States, Burlingame
Co-Investments: 4
Casdin Capital
Casdin Capital
North America, New York, United States, New York
Co-Investments: 6
8VC
8VC
North America, California, United States, San Francisco
Co-Investments: 5
Section 32
Section 32
North America, California, United States, San Diego
Co-Investments: 6
Threshold
Threshold
North America, California, United States, Menlo Park
Co-Investments: 6
ARCH Venture Partners
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 5

Which angels does Lifeforce Capital often collaborate with?

CG
Chris Gibson
North America, Utah, United States, Salt Lake City
Shared Deals: 2
DM
Shared Deals: 1
SI
Sami Inkinen
North America, Colorado, United States, Denver
Shared Deals: 1
JW
Jeff Weiner
North America, California, United States, Mountain View
Shared Deals: 1
DP
Shared Deals: 1
HT
Halle Tecco
North America, California, United States, San Francisco
Shared Deals: 2
AS
Andy Slavitt
North America, Maryland, United States, Baltimore
Shared Deals: 1
MA
Milad Alucozai
North America, California, United States, San Francisco
Shared Deals: 2
NC
Nelson Chu
North America, New York, United States, New York
Shared Deals: 1
MC
Martin Chavez
North America, New York, United States, New York
Shared Deals: 2

What are some of recent deals done by Lifeforce Capital?

Vilya

Seattle, Washington, United States

Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease.

BiotechnologyHealth DiagnosticsLife ScienceMedical
Series AJun 4, 2024
Amount Raised: $21,000,000
Ochre Bio

Oxford, Oxfordshire, United Kingdom

Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.

BiopharmaBiotechnologyHealth CareTherapeutics
Series AOct 10, 2022
Amount Raised: $30,000,000
Transition Bio

Cambridge, Massachusetts, United States

Transition Bio provides condensate technology for drug discovery and diagnostics.

BiotechnologyHealth CareHealth DiagnosticsMedical
Series AJun 2, 2022
Amount Raised: $50,000,000
MindRight Health

Newark, New Jersey, United States

MindRight Health offers culturally-responsive mental health coaching over a text message.

Health CareMental HealthPsychologySMS
SeedMay 24, 2022
Amount Raised: $1,780,000
Character Biosciences

Jersey City, New Jersey, United States

Biopharmaceutical research and development company

BiotechnologyClinical TrialsHealth CareHealth DiagnosticsPharmaceutical
Series AMay 17, 2022
Amount Raised: $18,000,000
Aspen Neuroscience

San Diego, California, United States

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series BMay 9, 2022
Amount Raised: $147,500,000
Cylinder

Chicago, Illinois, United States

Cylinder is a digital health company that offers personalized care for people with digestive conditions.

Health CareTelehealthWellness
Series AMar 8, 2022
Amount Raised: $16,000,000
Synapticure

Chicago, Illinois, United States

We provide neurodegenerative disease patients with expert MDs and 24/7 wrap around care, no matter where you live in the US

Health CareMedicalNeuroscienceWellness
SeedFeb 2, 2022
Amount Raised: $6,000,000
64x Bio

San Francisco, California, United States

64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery.

BiopharmaBiotechnologyGeneticsLife SciencePharmaceutical
Series AJan 19, 2022
Amount Raised: $55,000,000
PostEra

Boston, Massachusetts, United States

PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to bring more cures to patients

Artificial Intelligence (AI)BiotechnologyMachine LearningPharmaceuticalTherapeutics
Series AJan 11, 2022
Amount Raised: $24,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator